MUC1 and neoplasm: GT-00AxIL15 is a novel immunocytokine designed to direct the highly potent immune cell stimulator IL-15 to the tumor and its microenvironment via its TA-MUC1-targeting mAb moiety thereby improving its PK/PD properties and anti-tumor efficacy.